Robert M. Chanock

American pediatrician and virologist (1924-2010)

DBpedia resource is: http://dbpedia.org/resource/Robert_M._Chanock

Abstract is: Robert Merritt Chanock (July 8, 1924 – July 30, 2010) was an American pediatrician and virologist who made major contributions to the prevention and treatment of childhood respiratory infections in more than 50 years spent at the National Institute of Allergy and Infectious Diseases. Chanock was born July 8, 1924 in Chicago. His post-secondary plans were to study physics. When he was drafted by the United States Army in 1943, he was given the choice of attending medical school with his course of study paid for by the military or going to the front lines. Chanock passed the entrance examination and graduated from the University of Chicago in 1945 and the University of Chicago School of Medicine in 1947. He did his internship at Highland Hospital in Oakland and trained in pediatrics at the University of Chicago. After completing his medical training, he did a fellowship at Cincinnati's Children's Hospital, where he worked under Albert Sabin, who called Chanock his "star scientific son." He was drafted by the Army in 1952 and was sent to Korea to help deal with an outbreak of Japanese encephalitis, but a ruptured appendix forced him to Tokyo, where he did research on infectious disease. He returned to Children's Hospital after being released from Army duty, and later did research at the University of Cincinnati and Johns Hopkins University. He joined the National Institute of Allergy and Infectious Diseases, where he discovered the human respiratory syncytial virus, which is the cause of respiratory tract infections in children each winter, and is one of the most common causes of illness. Asked the best means to prevent the disease, Chanock quipped "one thing you can tell them is to have their babies in the spring". In 1962 Robert Chanock visited Dr. Leonard Hayflick at the Wistar Institute in Philadelphia, Pennsylvania, to obtain a culture of his normal human fetal cell strain, WI-38, because of Hayflick’s report that it replicated all of the then known human viruses. Chanock described his work with the “Eaton Agent” to Hayflick where it was assumed it to be the viral cause of Primary Atypical Pneumonia (PAP) or “walking pneumonia” in humans. This cause was never proven. Hayflick suggested to Chanock that the cause might be a mycoplasma (then called a PPLO). Hayflick wrote his thesis on mycoplasma causes of respiratory diseases in animals and suggested to Chanock that PAP might be caused by a mycoplasma. Chanock replied that he never heard of PPLO’s. At Hayflick’s request egg yolk in which the Eaton Agent was grown was sent to him by Chanock. Hayflick grew a mycoplasma, the smallest free-living microorganism, on a unique agar growth medium that he developed. Together they proved that it was the etiological agent of PAP. Hayflick named the organism Mycoplasma pneumoniae. Chanock was named head of the NIAID's Laboratory of Infectious Diseases in 1968. The WI-38 normal human cell strain gifted to Chanock resulted in the development of an adenovirus vaccine in 1964. This vaccine has been used in the world’s military where the virus produces a disease similar to the flu and forces recruits to enter clinics for many days. Researchers working with Chanock developed another vaccine using WI-38 to prevent Hepatitis A. They also produced a rotavirus vaccine, addressing the most common cause of severe diarrhoea in infants and young children, as well as an influenza virus vaccine in the form of a nasal spray. Efforts were undertaken to create a vaccine to deal with dengue fever, though efforts to create immunizations for para-influenza viruses and respiratory syncytial virus were unsuccessful. Chanock was elected to the United States National Academy of Sciences in 1973. He was also honored with the Robert Koch Prize, the Albert B. Sabin Gold Medal, the E. Mead Johnson Award, the Public Health Service's Meritorious Service Medal and Distinguished Service Medal. In 1972, he was presented with the Gorgas Medal from the Association of Military Surgeons of the United States (AMSUS). NIAID Director Dr. Anthony Fauci called Chanock "an outstanding scientist whose innumerable contributions to the understanding of viral diseases helped make the world a healthier place for millions of people". A resident of Bethesda, Maryland, Chanock died at age 86 on July 30, 2010, at an assisted living facility in Sykesville, Maryland, due to complications of Alzheimer's disease. He was survived by a son, Stephen Chanock, and four grandchildren.

Born 1924-07-08 in Chicago (Q1297)
Died 2010-07-30 in Sykesville (Q753667)

Robert M. Chanock is …
instance of (P31):
humanQ5

External links are
P2381Academic Tree ID47088
P268Bibliothèque nationale de France ID122804774
P5375BIU Santé person ID19472
P646Freebase ID/m/0cn_5nq
P227GND ID1236277252
P269IdRef ID031625754
P213ISNI0000000063049814
P244Library of Congress authority IDn83174608
P5380National Academy of Sciences member ID57011
P8189National Library of Israel J9U ID987007454671605171
P1006Nationale Thesaurus voor Auteursnamen ID070940193
P1207NUKAT IDn2014144546
P3368Prabook ID789141
P3430SNAC ARK IDw6072rzn
P214VIAF ID17283947
P10832WorldCat Entities IDE39PBJyMfMRd6MVFBXfwhbkbh3

P166award receivedBristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases ResearchQ30123947
Robert Koch PrizeQ505132
Howard Taylor Ricketts PrizeQ1631920
E. Mead Johnson AwardQ5322058
P509cause of deathAlzheimer's diseaseQ11081
P27country of citizenshipUnited States of AmericaQ30
P69educated atUniversity of ChicagoQ131252
Pritzker School of MedicineQ7245998
P108employerUniversity of CincinnatiQ153265
P101field of workMycoplasma pneumoniaeQ310904
antibodyQ79460
P735given nameRobertQ4927937
RobertQ4927937
P1050medical conditionAlzheimer's diseaseQ11081
P463member ofNational Academy of SciencesQ270794
P106occupationuniversity teacherQ1622272
virologistQ15634281
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q45852083A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype
Q43757792A DESCRIPTION OF SIX NEW RHINOVIRUSES OF HUMAN ORIGIN.
Q60305908A NEWLY IDENTIFIED ORAL MYCOPLASMA (M. ORALE) AND ITS RELATIONSHIP TO OTHER HUMAN MYCOPLASMAS
Q76923837A PILOT STUDY OF ACUTE RESPIRATORY ILLNESSES ON A COLLEGE CAMPUS
Q44503033A Radioimmunoprecipitation Test for Detection of Mycoplasma pneumoniae Antibody
Q46722393A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species
Q36259126A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production
Q45776569A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
Q43688474A complement-fixation test for measuring Australia antigen and antibody
Q72546841A dot hybridisation assay for detection of rotavirus
Q41458369A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees
Q36223151A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception
Q24560010A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals
Q45824647A micro-method for assay of neutralizing antibodies against parainfluenza virus types 1 and 3.
Q40758236A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools
Q37412249A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia
Q45822539A mutant of Parainfluenza type 1 virus with decreased capacity for growth at 38 C and 39 C.
Q45821424A seroepidemiologic study of adenovirus-associated virus infection in infants and children
Q78774577A study of the hemadsorption viruses (para-influenzae) and other viruses in children with and without respiratory disease
Q78437662ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION
Q45714896ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS.
Q45717128Acute respiratory disease associated with Coxsackie A-21 virus infection. II. Incidence in military personnel: observations in a nonrecruit population
Q76493115Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses
Q45717081Acute respiratory diseases of viral etiology. IV. Respiratory syncytial virus
Q35536527Acute respiratory diseases of viral etiology. V. Eaton agent: a review
Q78938945Acute respiratory diseases of viral etiology. VI. The newer enteroviruses
Q36330347Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.
Q27486791Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence
Q44693028An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test
Q40940832An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
Q67060689An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers
Q69977618An inactivated mycoplasma pneumoniae vaccine
Q45711711An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection
Q40984507An outbreak of parainfluenza 2 (croup-associated) virus infection. Association with acute undifferentiated febrile illness in children
Q40670956An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
Q37135981Analysis by RNA-RNA hybridization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo
Q37135965Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
Q68607295Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus
Q36812321Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus
Q34496791Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers
Q52853231Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation
Q39402028Antigenic Relationships among Five Reovirus-Like (RVL) Agents by Complement Fixation (CF) and Development of New Substitute CF Antigens for the Human RVL Agent of Infantile Gastroenteritis
Q45844407Antigenic analysis of a putative new strain of respiratory syncytial virus
Q36425412Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens
Q33795720Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4
Q43961692Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses
Q78634506Antigenic relationships among the newer myxoviruses (parainfluenza)
Q113501989Approaches to Immunization of Infants and Young Children Against Gastroenteritis Due to Rotaviruses
Q40121838Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses
Q78515429Association of hemadsorption viruses with respiratory illness in childhood
Q44693807Association of serum anti-neuraminidase antibody with resistance to influenza in man.
Q43210277Association of type 2 hemadsorption (parainfluenza 1) virus and Asian influenza A virus with infections croup
Q35129166Asymptomatic Infection of Adult Volunteers with a Temperature Sensitive Mutant of Mycoplasma pneumoniae
Q40593118Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
Q43891258Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses
Q46220282Biological Properties of Norwalk Agent of Acute Infectious Nonbacterial Gastroenteritis
Q35177108Biophysical Studies of Respiratory Syncytial Virus I. Density of Respiratory Syncytial Virus and Associated Complement-Fixing Antigens in a Cesium Chloride Density Gradient
Q37137809Biophysical properties of Australia antigen
Q35177143Biophysical studies of respiratory syncytial virus. II. Identification of two soluble complement-fixing antigens of respiratory syncytial virus
Q45076500Buoyant density in cesium chloride of the human reoviruslike agent of infantile gastroenteritis by ultracentrifugation, electron microscopy, and complement fixation
Q78231782CHARACTERIZATION OF A NEWLY IDENTIFIED MYCOPLASMA FROM THE HUMAN OROPHARYNX
Q64385000CLINICAL SYNDROMES AMONG CHILDREN
Q43672387Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection
Q36539117Characterization of a newly identified mycoplasma (Mycoplasma orale type 3) from the human oropharynx
Q36448181Characterization of the temperature sensitive phenotype of the A/Ann Arbor/6/60 cold-adapted virus and its recombinants
Q68561326Characterization of two newly recognized rhinovirus serotypes of human origin
Q45711479Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (SV40) by Respiratory Route
Q45821276Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus
Q40079464Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children
Q78614269Clinical features of infection with hemadsorption viruses
Q36351027Cloning DNA sequences from influenza viral RNA segments
Q40803999Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins
Q36685348Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant
Q67050806Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain
Q34077963Cold-Adapted Variants of Influenza A Virus: Evaluation in Adult Seronegative Volunteers of A/Scotland/840/74 and A/Victoria/3/75 Cold-Adapted Recombinants Derived from the Cold-Adapted A/Ann Arbor/6/60 Strain
Q45888109Cold-adapted variants of influenza virus A. I. Comparison of the genetic properties of ts mutants and five cold-adapted variants of influenza virus A
Q41343225Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization
Q37387362Color test for the measurement of antibody to T-strain mycoplasmas.
Q40268332Common Exposure Outbreak of Gastroenteritis Due to Type 2 Rotavirus with High Secondary Attack Rate within Families
Q36881401Comparative analysis of the VP3 gene of divergent strains of the rotaviruses simian SA11 and bovine Nebraska calf diarrhea virus
Q40249473Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis
Q42638802Comparative sequence analysis of the genomic segment 6 of four rotaviruses each with a different subgroup specificity
Q37336197Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children
Q40155541Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA
Q40500583Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys
Q68603708Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness
Q69810619Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes
Q67295052Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers
Q37399901Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection
Q36870349Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation
Q37605064Construction and characterization of cDNA clones for four respiratory syncytial viral genes
Q41119652Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity
Q52443988Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.
Q36868367Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.
Q37167128Cultivation of Mycoplasmas on Glass
Q39272631Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses
Q34276842Current research on respiratory viral infections: Third International Symposium
Q36328822Definition of human rotavirus serotypes by plaque reduction assay.
Q43976838Demonstration of a non-temperature-sensitive growth-restricting mutation in a ts mutant of influenza A virus: implications for live virus vaccine development
Q27480386Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys
Q69382696Density in cesium chloride of the 27 nm "8FIIa" particle associated with acute infectious nonbacterial gastroenteritis: determination by ultra-centrifugation and immune electron microscopy
Q35178789Density of infectious virus and complement-fixing antigens of two rhinovirus strains
Q41224602Detection by Immune Electron Microscopy of 26- to 27-nm Viruslike Particles Associated with Two Family Outbreaks of Gastroenteritis
Q70181981Development of vaccines against rotavirus disease
Q40235270Diarrhea Associated with Rotavirus in Rural Guatemala: A Longitudinal Study of 24 Infants and Young Children *
Q67858173Differentiation of human and calf reoviruslike agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA
Q37208256Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
Q36427864Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2
Q36348455Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus
Q44133962Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers
Q44479655EFFECT OF NEUTRALIZING ANTIBODY ON EXPERIMENTAL RHINOVIRUS INFECTION.
Q64384460ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA IN A MILITARY POPULATION
Q76606558EVALUATION OF A NEW ANALEPTIC: ETHAMIVAN (EMIVAN)
Q78392729EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION
Q79062684Ear involvement (myringitis) and primary atypical pneumonia following inoculation of volunteers with Eaton agent
Q79028006Eaton Agent Pneumonia— Clinical Features
Q78814824Eaton agent pneumonia
Q79045881Eaton agent pneumonia
Q45717969Ecology of a newly recognized common respiratory agent RS virus. Combined clinical staff conference at the National Institutes of Health
Q39949753Effect of 2-deoxy-D-glucose and glucosamine on the growth and functions of respiratory syncytial and parainfluenza 3 viruses
Q37212728Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
Q45824565Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers
Q36888695Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.
Q41073880Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children
Q68666293Electron microscopic studies of respiratory syncytial temperature-sensitive mutants
Q71846693Electron microscopy of solubilized Acholeplasma laidlawii membrane proteins reaggregated with Mycoplasma pneumoniae glycolipids
Q36787262Electrophoretic analysis of cell proteins of T-strain mycoplasmas isolated from man.
Q37314978Enhancement of antigen incorporation and infectivity of cell cultures by human rotavirus
Q36858777Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus
Q40154842Enzyme-Linked Immunosorbent Assay for Identification of Rotaviruses from Different Animal Species
Q39446107Enzyme-linked immunosorbent assay (ELISA) for detection of human reovirus-like agent of infantile gastroenteritis
Q34447185Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection
Q40180027Epidemiology of Human Rotavirus Types 1 and 2 as Studied by Enzyme-Linked Immunosorbent Assay
Q70918166Epidemiology of M. pneumoniae infection in military recruits
Q45819240Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics
Q45819346Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection
Q45819313Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
Q45793645Escape of a highly defective influenza A virus mutant from its temperature sensitive phenotype by extragenic suppression and other types of mutation
Q64383647Establishment of human fetal intestinal organ cultures for growth of viruses
Q68554840Etiology of upper-respiratory-tract illnesses among civilian adults
Q45849259Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus
Q43756145Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus
Q36447392Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers
Q45814376Evaluation of Low Temperature Grown Influenza A2/Hong Kong Virus in Volunteers
Q40614352Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
Q36441027Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses
Q45814307Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults
Q53760664Evaluation of an interferon inducer in viral respiratory disease.
Q39640529Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness
Q39640522Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection
Q33906019Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers
Q70138090Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children
Q44621708Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults
Q33903684Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys
Q70299796Evidence for intrasegmental complementation between two influenza A viruses having ts mutations on their P1 genes
Q54799013Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.
Q46849786Experimental Mycoplasma pneumoniae infection of young guinea pigs
Q39607959Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis
Q34450565Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus
Q44476168Experimental production of respiratory tract infection with Mycoplasma pneumoniae in rhesus monkeys
Q44526388Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness
Q41378865Experimental respiratory syncytial virus infection of four species of primates
Q40166739Experimental respiratory syncytial virus pneumonia in cebus monkeys
Q27486998Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus
Q37401975Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity
Q34123210Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus
Q78787282Family Outbreak of Primary Atypical Pneumonia Associated with the Eaton Agent
Q68898649Functional expression of influenza A viral nucleoprotein in cells transformed with cloned DNA
Q37506955Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus
Q54093958Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine.
Q77148408Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18
Q44026072Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.
Q37388532Genetic Differentiation by Nucleic Acid Homology II. Genotypic Variations Within Two Mycoplasma Species.
Q36331387Genetic Relatedness Among Human Rotaviruses as Determined by RNA Hybridization
Q45814900Genetic alteration in a temperature-sensitive mutant of respiratory syncytial virus after replication in vivo.
Q72423822Genetic approaches to attenuation of influenza A viruses for man
Q41704032Genetic approaches to control of influenza
Q86508589Genetic approaches to control of influenza
Q37388519Genetic differentiation by nucleic Acid homology I. Relationships among Mycoplasma species of man.
Q70918257Genetic differentiation by nucleic acid homology. 3. Relationships among mycoplasma, L-forms, and bacteria
Q70850524Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo
Q70125909Genetic relatedness among animal rotaviruses
Q37215560Genetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification
Q70106401Genetic relatedness among human rotaviruses
Q36874536Genetic stability of rotaviruses recovered from asymptomatic neonatal infections.
Q44901435Genetic studies of respiratory syncytial virus temperature-sensitive mutants
Q72889609Genetic variation of influenza A viruses as studied by recombinant DNA techniques
Q44004532Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets
Q37499226Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures
Q36452987Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease
Q79364977Growth of Eaton PPLO in broth and preparation of complement fixing antigen
Q69826222Growth of Mycoplasma pneumoniae on a glass surface
Q78814725Growth of laboratory and naturally occurring strains of Eaton agent in monkey kidney tissue culture
Q78852698Growth of the Eaton agent of primary atypical pneumonia in chick entodermal tissue culture
Q33790712Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.
Q37416821HEMOLYSIN OF MYCOPLASMA PNEUMONIAE.
Q46853811Hemadsorption by Coronavirus Strain OC43
Q78470464Hemadsorption viruses in infections of the respiratory tract of children; preliminary report
Q45717758Hemagglutination by Coe virus
Q37334066Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses
Q44674371Hemagglutinins of the St. Louis and western equine encephalitis viruses: isolation, properties, and use for diagnosis and epidemiologic survey
Q79619634Hemolyin production as an aid in the identification and quantitation of Eaton agent (Mycoplasma pneumoniae)
Q46847840Hemolysin of Mycoplasma pneumoniae : Tentative Identification as a Peroxide
Q39981162Human Reovirus-like Agent as the Major Pathogen Associated with “Winter” Gastroenteritis in Hospitalized Infants and Young Children
Q43459480Human Rotavirus Type 2: Cultivation in Vitro
Q33177627Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines
Q30946151Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity
Q36749095Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases
Q40079834Human reovirus-like agent infection. Occurrence in adult contacts of pediatric patients with gastroenteritis
Q40781870Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children
Q44228207IMMUNIZATION WITH TYPES 4 AND 7 ADENOVIRUS BY SELECTIVE INFECTION OF THE INTESTINAL TRACT
Q34417358INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS
Q76606555INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA
Q72783237Identification of acid-inducing agent and related mycoplasma as mycoplasma hyorhinis
Q36871958Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
Q54027800Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.
Q64384347Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers
Q45843731Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
Q37829340Immunization of infants and young children against rotaviral gastroenteritis--prospects and problems
Q27486871Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis
Q39243877Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge
Q57115195Immunoenzymatic examination of autoptic tissues from the outbreak of fatal infantile disease in Naples, in 1978-1979
Q45711661Immunofluorescence with respiratory syncytial virus
Q70727788Immunogenicity of Cytolipin H Aggregated with Acholeplasma laidlawii Membrane Proteins
Q33704894Immunogenicity of Mycoplasma pneumoniae glycolipids: a novel approach to the production of antisera to membrane lipids
Q45868590Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee
Q45826022Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines
Q42978288Immunologic studies of Japanese encephalitis virus in Japan. I. Antibody responses following overt infection of man.
Q42980030Immunologic studies of Japanese encephalitis virus in Japan. II. Antibody responses following inapparent human infection
Q34076830Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay
Q45828600Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.
Q34429476Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters
Q34429422Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine
Q45843845Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants
Q69358520In Vitro Cultivation in Human Fetal Intestinal Organ Culture of a Reovirus-Like Agent Associated with Nonbacterial Gastroenteritis in Infants and Children
Q36924285In vitro transcription of two human rotaviruses.
Q76467886In vivo antigenic studies of parainfluenza viruses
Q71198207Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers
Q37558684Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity
Q44458040Induction of diarrhea in colostrum-deprived newborn rhesus monkeys with the human reovirus-like agent of infantile gastroenteritis
Q36875550Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen
Q44245973Infection of hamsters with para influenza 3 virus
Q45718983Infection of human volunteers with type 2 hemadsorption virus
Q64383775Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome
Q64383221Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season
Q45829625Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys
Q45821905Influence of immunological factors in respiratory syncytial virus disease
Q41599669Influenza A and B virus infection in infants and young children during the years 1957-1976
Q39917473Inhibition of respiratory syncytial, parainfluenza 3 and measles viruses by 2-deoxy-d-glucose
Q45711707Inoculation of Human Volunteers with Parainfluenza Virus Type 3
Q70367619Intracellular Development and Mechanism of Hemadsorption of a Human Coronavirus, OC43
Q34080111Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats
Q35181395Isolation and Characterization of Fractions of Mycoplasma pneumoniae II. Antigenicity and Immunogenicity
Q36933029Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus
Q45789084Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus
Q35181362Isolation and characterization of fractions of Mycoplasma pneumoniae. I. Chemical and chromatographic separation
Q45887448Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus
Q45813839Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations
Q45814906Isolation of RNA species from HeLa cells infected with respiratory syncytial virus
Q32071192Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo
Q41335274Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine
Q39362354Letter: Probable in-vitro cultivation of human reovirus-like agent of infantile diarroea
Q30409789Live Victoria/75- ts -1[E] Influenza A Virus Vaccines in Adult Volunteers: Role of Hemagglutinin Immunity in Protection Against Illness and Infection Caused by Influenza A Virus
Q45771373Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates
Q39227933Live viral vaccines for respiratory and enteric tract diseases
Q45791386Localization of the Ts defect in two Ts mutants of influenza A virus: evidence for the occurrence of intracistronic complementation between Ts mutants of influenza A virus coding for the neuraminidase and nucleoprotein polypeptides
Q45810536Low-Temperature-Grown RS Virus in Adult Volunteers
Q47756461Lysis and death of Mycoplasma pneumoniae by antibody and complement
Q24562547MYCOPLASMA SPECIES OF MAN
Q76567966MYXOVIRUSES: PARAINFLUENZA
Q69178677Measurement of Mycoplasma pneumoniae mycoplasmacidal antibody in human serum
Q37363527Measurement of rotavirus antibody by an enzyme-linked immunosorbent assay blocking assay
Q36808652Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats
Q37103582Mechanisms of immunity to respiratory syncytial virus in cotton rats
Q27486619Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis
Q34414157Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin
Q40549292Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus
Q40983230Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein
Q46380644More Sensitive Methods for Detection of Antibody to Mycoplasma pneumoniae
Q37122632Morphogenesis of Avian Infectious Bronchitis Virus and a Related Human Virus (Strain 229E)
Q45711465Multiplication and Cytopathology of Coxsackie A-21 Virus in Rotated and Stationary Tissue Culture
Q71260541Mutants of influenza virus
Q46184613Mycoplasma contamination in cell culture of Crohn's disease material
Q71468617Mycoplasma pneumoniae Phosphatidyl Glycerol
Q47821347Mycoplasma pneumoniae infections in volunteers
Q45711734Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease
Q40486736Neonatal administration of rhesus rotavirus tetravalent vaccine
Q39328200New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen
Q30444491New viruses observed in children with respiratory diseases
Q74791885Newly recognized myxoviruses from children with respiratory disease
Q36899094Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract
Q43873684Nucleoprotein and membrane protein genes responsible for restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in the respiratory tract of squirrel monkeys
Q45848527Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses
Q67258021Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance
Q64384515PATTERNS OF ADENOVIRUS INFECTIONS IN MARINE CORPS PERSONNEL. I. A 42-MONTH SURVEY IN RECRUIT AND NONRECRUIT POPULATIONS
Q64384514PATTERNS OF ADENOVIRUS INFECTIONS IN MARINE CORPS PERSONNEL. II. LONGITUDINAL STUDY OF SUCCESSIVE ADVANCED RECRUIT TRAINING COMPANIES
Q64384989PATTERNS OF ILLNESS IN RHINOVIRUS INFECTIONS OF MILITARY PERSONNEL
Q45711672Para-influenza 2 (CA) virus: etiologic association with croup.
Q36333406Parenteral immunization with live respiratory syncytial virus is blocked in seropositive cotton rats
Q36873249Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
Q36638969Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus).
Q57116104Pattern of Shedding of the Norwalk Particle in Stools during Experimentally Induced Gastroenteritis in Volunteers as Determined by Immune Electron Microscopy
Q37254420Pediatric viral gastroenteritis during eight years of study
Q72147606Peroxide Formation by Mycoplasmas which Infect Man
Q70918174Phospholipid hapten of Mycoplasma pneumoniae
Q79447510Picornaviruses: classification of nine new types
Q44069994Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations
Q39927986Potential of attenuated respiratory syncytial virus vaccine for infants and children
Q36867574Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene
Q46429295Preparation and Characterization of Complement-fixing Hepatitis-associated Antigen and Antiserum
Q39809764Present status of live influenza A virus vaccine
Q40198967Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay
Q34095271Prevalence of antibody to the Norwalk virus in various countries
Q44176827Probable association of plaque size with neuraminidase subtype among H3N2 influenza A viruses
Q34167897Production and Properties of Antisera to Membrane Glycolipids of Mycoplasma pneumoniae
Q36329504Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations
Q33707803Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va
Q27486615Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a
Q38284480Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children
Q43722598Prospects for prevention of bronchiolitis caused by respiratory syncytial virus
Q46129217Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants
Q45824738Protective effect of antibody to parainfluenza type 1 virus
Q30414067Proteins of Norwalk virus
Q36903965Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats
Q76505744RELATIONSHIP OF RHINOVIRUS INFECTION TO MILD UPPER RESPIRATORY DISEASE. 1. RESULTS OF A SURVEY IN YOUNG ADULTS AND CHILDREN
Q77182858RELATIONSHIP OF RHINOVIRUS INFECTION TO MILD UPPER RESPIRATORY DISEASE. II. EPIDEMIOLOGIC OBSERVATIONS IN MALE MILITARY TRAINEES
Q76583869RHINOVIRUS NEUTRALIZING ANTIBODY RESPONSES AND THEIR MEASUREMENT
Q44704693ROLE OF MYCOPLASMA (PPLO) IN HUMAN RESPIRATORY DISEASE
Q33765907Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.
Q56762470Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions
Q36899609Reassortant rotaviruses as potential live rotavirus vaccine candidates
Q45805045Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys
Q37214942Recent Advances in the Aetiology of Viral Gastroenteritis
Q36467073Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children
Q35046469Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
Q50730224Recommendations on nomenclature of the order Mycoplasmatales.
Q35548175Recovery and identification of adenovirus in infections of infants and children.
Q35548219Recovery and identification of human myxoviruses
Q36465731Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease
Q79364978Recovery of PPLO of atypical pneumonia on artificial agar medium
Q95555907Recovery of PPLO of atypicalpneumonia on artificial agar medium. (MR005.1204)
Q69589697Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology
Q35171341Relationship of Mycoplasma pneumoniae to Other Human Mycoplasma Species Studied by Gel Diffusion
Q34095336Relationship of genotype of recombinants of influenza A/Hong Kong/68-ts-1[E]virus used as live virus vaccines to virulence in humans
Q78762766Relationship of human and bovine strains of myxovirus para-influenza 3
Q68558290Relationship of rehinovirus infection to mild upper respiratory disease. 3. Further epidemiologic observations in military personnel
Q69355598Reoviruslike Agent in Stools: Association with Infantile Diarrhea and Development of Serologic Tests
Q35308902Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus
Q35596022Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein
Q36404814Respiratory disease in volunteers infected with Eaton agent: a preliminary report
Q45791662Respiratory syncytial virus antibodies in nonhuman primates and domestic animals
Q34206177Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
Q43599145Respiratory syncytial virus in infants and children
Q36330105Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats
Q34098698Respiratory syncytial virus infection in inbred mice
Q34100392Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants
Q45813801Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection
Q45718423Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children
Q45718142Respiratory syncytial virus. II. Serologic studies over a 34-month period of children with bronchiolitis, pneumonia, and minor respiratory diseases.
Q45717993Respiratory syncytial virus. III. Production of illness and clinical observations in adult volunteers.
Q45717756Respiratory syncytial virus. IV. Correlation of virus shedding, serologic response, and illness in adult volunteers.
Q55515289Role of Eaton agent in disease of lower respiratory tract: evidence for infection in adults.
Q34155278Role of Glycolipids and Phosphatidylglycerol in the Serological Activity of Mycoplasma pneumoniae
Q40225222Role of Norwalk Virus in Outbreaks of Nonbacterial Gastroenteritis
Q33741620Role of early genes in pathogenesis of adenovirus pneumonia
Q33858906Role of early region 3 (E3) in pathogenesis of adenovirus disease
Q40200919Rotaviral Immunity in Gnotobiotic Calves: Heterologous Resistance to Human Virus Induced by Bovine Virus
Q48291317Rotavirus VP7 neutralization epitopes of serotype 3 strains
Q72860885Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital
Q39501137Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination
Q37438212SEROLOGICAL RELATIONSHIPS AMONG HUMAN MYCOPLASMAS AS SHOWN BY COMPLEMENT-FIXATION AND GEL DIFFUSION
Q78300354SIGNIFICANCE OF ANTIBODY TO MYCOPLASMA HOMINIS TYPE 1 AS MEASURED BY INDIRECT HEMAGGLUTINATION
Q45890352Safety and Antigenicity of Inactivated Influenza Virus Vaccines in Children: Trials with Monovalent and Bivalent A/New Jersey/76 (HswN1) and A/Victoria/75 Virus Vaccines in Washington, D.C
Q44262730Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
Q70154380Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine
Q40475001Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Q41463572Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis
Q33912830Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
Q39205546Secretory antibody directed against rotavirus in human milk—measurement by means of enzyme-linked immunosorbent assay
Q36637434Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro
Q70112230Sensitivity of common respiratory viruses to an interferon inducer in human cells
Q36879244Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections.
Q46702794Sequential enteric illnesses associated with different rotavirus serotypes
Q36203580Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization
Q43210782Serious respiratory tract illness as a result of Asian influenza and influenza B infections in children
Q53815035Seroepidemiologic studies of coronavirus infection in adults and children.
Q45053573Seroepidemiological studies of transfusion-associated hepatitis
Q79189893Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood
Q78814832Serologic response of incividuals infected with para influenza viruses
Q71175805Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection
Q44032340Serologic response to Myocplasma pneumoniae infection. II. Significance of antibody measured by different techniques
Q70918219Serological and immunogenic activities of different fractions of Mycoplasma pneumoniae
Q37205945Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
Q43566533Serum complement in acute bronchiolitis
Q37208820Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.
Q72216366Shedding ofMycoplasma pneumoniaeafter Tetracycline and Erythromycin Therapy
Q70918216Significance of antibody to mycoplasma as measured by metabolic-inhibition techniques
Q37212147Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.
Q44388606Site-directed ELISA identifies a highly antigenic region of the simian immunodeficiency virus transmembrane glycoprotein
Q37312274Solid-Phase Microtiter Radioimmunoassay Blocking Test for Detection of Antibodies to Escherichia coli Heat-Labile Enterotoxin
Q39607962Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies
Q45825523Specificity of the local secretory antibody to influenza A virus infection.
Q38321647Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines.
Q52850498Studies in volunteers with human rotaviruses
Q43846948Studies of a new human hemadsorption virus. I. Isolation, properties and characterization.
Q45827861Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model
Q70457314Studies with human coronaviruses. II. Some properties of strains 229E and OC43
Q76567978THE ROLE OF ENTEROVIRUSES IN RESPIRATORY DISEASE
Q45883792Temperature sensitive mutants of influenza virus. IX. Genetic and biological characterization of TS-1[E] lesions when transferred to a 1972 (H3N2) influenza A virus
Q45811202Temperature-Sensitive Mutants of Influenza Virus. I. Behavior in Tissue Culture and in Experimental Animals
Q45815368Temperature-Sensitive Mutants of Influenza Virus. III. Further Characterization of the ts-1[E] Influenza A Recombinant (H3N2) Virus in Man
Q45815366Temperature-Sensitive Mutants of Influenza Virus. IV. Induction of Interferon in the Nasopharynx by Wild-Type and a Temperature-Sensitive Recombinant Virus
Q69887343Temperature-Sensitive Mutants of Mycoplasma pneumoniae: I. In Vitro Biologic Properties
Q70614865Temperature-Sensitive Mutants of Mycoplasma pneumotuae. II. Response of Hamsters
Q45811483Temperature-Sensitive Mutants of Respiratory Syncytial Virus: In-Vivo Studies in Hamsters
Q39145234Temperature-Sensitive Mutants of Streptococcus pneumoniae. I. Preparation and Characterization in Vitro of TemperatureSensitive Mutants of Type I S. pneumoniae
Q39160693Temperature-Sensitive Mutants of Type I Streptococcus pneumoniae: Preparation, Characterization, and Evidence for Attenuation and Immunogenicity
Q43757749Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens
Q40890762Temperature-sensitive Mutants of Influenza A Virus: Response of Children to the Influenza A/Hong Kong/68-ts-1[E] (H3N2) and Influenza A/Udorn/72-ts-1[E] (H3N2) Candidate Vaccine Viruses and Significance of Immunity to Neuraminidase Antigen
Q37133871Temperature-sensitive Mutants of Respiratory Syncytial Virus
Q43465179Temperature-sensitive mutants of influenza A virus. Transfer of the two ts-1A2 ts lesions present in the Udorn/72-ts-1A2 donor virus to the influenza A/Alaska/6/77 (H3N2) wild type virus
Q45885602Temperature-sensitive mutants of influenza A virus. XI. Transfer of ts lesions in the Hong Kong/68-ts-1 [a] virus to the influenza A/Udorn/72 wild type
Q45885600Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults
Q45887369Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults
Q30413824Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers
Q34077937Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers
Q45791038Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers
Q34447272Temperature-sensitive mutants of influenza A virus: production and characterization of A/Victoria/3/75-ts-1[E] recombinants
Q33903865Temperature-sensitive mutants of influenza A virus: transfer of the two temperature-sensitive lesions in the Udorn/72-ts-1A2 virus to the A2Hong Kong/123/77 (H1N1) wild-type virus
Q45792982Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity
Q45792980Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. II. Genetic analysis and demonstration of intrasegmental complementation
Q45794150Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. III. Genetic analysis of temperature-dependent host range mutants
Q45816030Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.
Q45791430Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation
Q45814802Temperature-sensitive mutants of influenza virus. V. Evaluation in man of an additional ts recombinant virus with a 39 C shutoff temperature
Q43207571Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2)
Q45889637Temperature-sensitive mutants of influenza virus. XV. The genetic and biological characterization of a recombinant influenza virus containing two ts lesions produced by mating two complementing, single lesion ts mutants
Q45889633Temperature-sensitive mutants of influenza virus. XVI. Transfer of the two ts lesions present in the Udorn/72-ts-1A2 donor virus to the Victoria/3/75 wild-type virus
Q44553913Temperature-sensitive mutants of influenza. VIII. Genetic and biological characterization of TS mutants of influenza virus A (H3N2) and their assignment to complementation groups
Q93811682The adaptation of two human coronavirus strains (OC38 and OC43) to growth in cell monolayers
Q42977111The hemagglutinin of St. Louis encephalitis virus. I. Recovery of stable hemagglutinin from the brains of infected mice
Q42977117The hemagglutinin of St. Louis encephalitis virus. II. Physico-chemical properties and nature of its reaction with erythrocytes
Q42977120The hemagglutinin of St. Louis encephalitis virus. III. Properties of normal inhibitors and specific antibody; use of hemagglutination-inhibition for diagnosis of infection
Q42977405The hemagglutinin of West Nile virus: recovery, properties, and antigenic relationships
Q45720869The hemagglutinin of western equine encephalitis virus: recovery, properties and use for diagnosis.
Q40795113The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins
Q36058867The pathogenesis of respiratory syncytial virus infection in cotton rats
Q64384119The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults
Q45829807The use of purified immunoglobulin in the therapy of respiratory syncytial virus infection
Q35319145Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys
Q70580714Transmission of Acute Infectious Nonbacterial Gastroenteritis to Volunteers by Oral Administration of Stool Filtrates
Q48660698Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971.
Q34483591Ultrastructural Lesions in Mycoplasma pneumoniae Membranes Produced by Antibody and Complement
Q40765950Unexpectedly High Frequency of Antibody to Mycoplasma pneumoniae in Human Sera as Measured by Sensitive Techniques
Q34406224Use of a free viral immunofluorescence assay to detect human reovirus-like agent in human stools
Q30414968Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease
Q36811328Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children
Q33905975Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines
Q72954807Use of transcription probes for genotyping rotavirus reassortants
Q46156185VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies
Q34162702VP7 serotype-specific glycoprotein of OSU porcine rotavirus: coding assignment and gene sequence
Q43522294Vaccination against pediatric illness caused by parainfluenza virus, respiratory syncytial virus and certain adenoviruses. Current status and perspective
Q37866604Viral diarrhea. Etiology and control
Q36333583Virulence of avian influenza A viruses for squirrel monkeys.
Q36591307Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis
Q45793768ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus

winner (P1346)
Q30123947Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases Research
Q505132Robert Koch Prize

main subject (P921)
Q123691040Dr. Robert M. Chanock, Prominent Virologist, Dies at 86
Q34910434In Memoriam: Robert M. Chanock, MD, 1924–2010.

The articles in Wikimedia projects and languages

Arabic (ar / Q13955)روبرت ميريت شانوكwikipedia
Egyptian Arabic (arz / Q29919)روبرت ميريت شانوكwikipedia
      Robert M. Chanockwikipedia
      Robert M. Chanockwikipedia

Search more.